In order to understand the complex signaling paths that lead to mechanisms of resistance to FGFR1 inhibition in lung cancer, we here performed for the first time a large-scale mass-spectrometric phosphoproteomic analysis of FGFR1-amplified lung cancer cells. This evidence concerns the gene FGFR1 and lung cancer.